Related Experiment Videos
Psychiatric aspects of congestive heart failure: implications for consulting psychiatrists
1Department of Medicine, Cleveland Metropolitan General Hospital, Ohio 44109.
Insights
Mental function abnormalities are common in congestive heart failure patients. Careful psychotropic drug management is crucial, considering cardiovascular effects and potential toxicity in heart failure.
Area of Science:
- Cardiology
- Psychiatry
- Clinical Pharmacology
Background:
- Mental dysfunction is prevalent in congestive heart failure (CHF) patients, worsening with disease progression.
- Cerebral blood flow is maintained in mild CHF but compromised in advanced stages.
- Cardiac medications and psychotropic drugs can induce or exacerbate mental aberrations.
Purpose of the Study:
- To review the psychiatric manifestations in congestive heart failure patients.
- To discuss the cardiovascular effects of psychotropic medications in cardiac patients.
- To highlight challenges in managing mental symptoms alongside heart failure.
Main Methods:
- Literature review of psychiatric complications in CHF.
- Analysis of drug interactions between cardiac and psychotropic medications.
- Discussion of clinical management strategies for dual diagnoses.
Main Results:
- Heart failure progression impacts cognitive function.
- Digitalis, diuretics, and vasodilators can cause mental disturbances.
- Psychotropic drugs (antidepressants, antipsychotics, lithium) require careful dosing and monitoring due to cardiovascular risks and altered pharmacokinetics in CHF.
Conclusions:
- Managing mental symptoms in CHF patients is complex.
- Psychotropic drug selection and monitoring are critical to avoid adverse cardiovascular events.
- Close collaboration between cardiology and psychiatry is essential for optimal patient outcomes.
Abstract:
Abnormalities of mental function are common problems in patients with congestive heart failure, a problem that is often referred to the consulting psychiatrist. These abnormalities become more frequent and more serious as failure of the heart progresses and they can exhibit a wide variety of manifestations. Cardiac output and cerebral blood flow are preserved due to compensatory mechanisms in mild heart failure but can be severely compromised in advanced failure. Drugs used to treat heart failure, especially digitalis, can produce a wide variety of mental aberrations including delirium, usually when these drugs are used in excess. Diuretics can produce electrolyte abnormalities resulting in mental derangements and vasodilator therapy can produce hypotension. Psychotropic drugs are well recognized as having significant cardiovascular effects that need to be considered when these agents are applied to the cardiac patient. Antidepressant and antipsychotic drugs have anticholinergic, antiadrenergic and quinidine-like effects that can produce further cardiac decompensation in heart failure. Antidepressants are generally well tolerated except when toxic levels occur or in the most extremely compromised cardiac patients. Monoamine oxidase inhibitors should be used only in highly reliable patients to avoid the acute hypertensive crises that are well known to occur with these agents. Antipsychotic drugs with limited cardiovascular side effects can be used effectively and safely but care must be taken to avoid toxic levels which could produce excess hypotension or lethal arrhythmias. Lithium can also be used in heart failure if patients are effectively monitored to avoid toxic levels which could occur due to reduction in renal function, use of diuretics or imposition of a low sodium chloride diet. Evaluation and management of patients with mental symptoms and heart failure provides a strong challenge for the consulting psychiatrist.
Related Concept Videos
Heart Failure I: Introduction
Heart Failure III: Clinical Manifestations
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Cardiomyopathy V: Interprofessional Care